|
1
|
Minniti G, Muni R, Lanzetta G, Marchetti P
and Enrici RM: Chemotherapy for glioblastoma: current treatment and
future perspectives for cytotoxic and targeted agents. Anticancer
Res. 29:5171–5184. 2009.PubMed/NCBI
|
|
2
|
Quick A, Patel D, Hadziahmetovic M,
Chakravarti A and Mehta M: Current therapeutic paradigms in
glioblastoma. Rev Recent Clin Trials. 5:14–27. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lino M and Merlo A: Translating biology
into clinic: the case of glioblastoma. Curr Opin Cell Biol.
21:311–316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yague JG, Lavaque E, Carretero J, Azcoitia
I and Garcia-Segura LM: Aromatase, the enzyme responsible for
estrogen biosynthesis, is expressed by human and rat glioblastomas.
Neurosci Lett. 368:279–284. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sribnick EA, Ray SK and Banik NL: Estrogen
prevents glutamate-induced apoptosis in C6 glioma cells by a
receptor-mediated mechanism. Neuroscience. 137:197–209. 2006.
View Article : Google Scholar
|
|
6
|
Hui AM, Zhang W, Chen W, Xi D, Purow B,
Friedman GC and Fine HA: Agents with selective estrogen receptor
(ER) modulator activity induce apoptosis in vitro and in vivo in
ER-negative glioma cells. Cancer Res. 64:9115–9123. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moodbidri MS and Shirsat NV: Activated JNK
brings about accelerated apoptosis of Bcl-2-overexpressing C6
glioma cells on treatment with tamoxifen. J Neurochem. 92:1–9.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tian F, Wu H, Li Z, Wang N, Huang J, Li C
and Xie F: Activated PKCalpha/ERK1/2 signaling inhibits
tamoxifen-induced apoptosis in C6 cells. Cancer Invest. 27:802–808.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Altiok N, Koyuturk M and Altiok S: JNK
pathway regulates estradiol-induced apoptosis in hormone-dependent
human breast cancer cells. Breast Cancer Res Treat. 105:247–254.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
McCarthy MM: The two faces of estradiol:
effects on the developing brain. Neuroscientist. 15:599–610. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Waters EM and Simerly RB: Estrogen induces
caspase-dependent cell death during hypothalamic development. J
Neurosci. 29:9714–9718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lewis-Wambi JS and Jordan VC: Estrogen
regulation of apoptosis: how can one hormone stimulate and inhibit?
Breast Cancer Res. 11:2062009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bennett BL, Sasaki DT, Murray BW, O’Leary
EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y,
Bhagwat SS, Manning AM and Anderson DW: SP600125, an
anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad
Sci USA. 98:13681–13686. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prieto LM, Brown JW, Perez-Stable C and
Fishman LM: High dose 17 beta-estradiol and the alpha-estrogen
agonist PPT trigger apoptosis in human adrenal carcinoma cells but
the beta-estrogen agonist DPN does not. Horm Metab Res. 40:311–314.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pozzi S, Benedusi V, Maggi A and Vegeto E:
Estrogen action in neuroprotection and brain inflammation. Ann N Y
Acad Sci. 1089:302–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morissette M, Le Saux M, D’Astous M,
Jourdain S, Al Sweidi S, Morin N, Estrada-Camerana E, Mendez P,
Garcia-Segura LM and Di Paolo T: Contribution of estrogen receptors
alpha and beta to the effects of estradiol in the brain. J Steroid
Biochem Mol Biol. 108:327–338. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raz L, Khan MM, Mahesh VB, Vadlamudi RK
and Brann DW: Rapid estrogen signaling in the brain. Neurosignals.
16:140–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Levin ER: Plasma membrane estrogen
receptors. Trends Endocrinol Metab. 20:477–482. 2009. View Article : Google Scholar
|
|
19
|
Waetzig V and Herdegen T: Context-specific
inhibition of JNKs: overcoming the dilemma of protection and
damage. Trends Pharmacol Sci. 26:455–461. 2005.PubMed/NCBI
|
|
20
|
Björkblom B, Vainio JC, Hongisto V,
Herdegen T, Courtney MJ and Coffey ET: All JNKs can kill, but
nuclear localization is critical for neuronal death. J Biol Chem.
283:19704–19713. 2008.PubMed/NCBI
|
|
21
|
Mhaidat NM, Zhang XD, Jiang CC and Hersey
P: Docetaxel-induced apoptosis of human melanoma is mediated by
activation of c-Jun NH2-terminal kinase and inhibited by the
mitogen-activated protein kinase extracellular signal-regulated
kinase 1/2 pathway. Clin Cancer Res. 13:1308–1314. 2007. View Article : Google Scholar
|
|
22
|
Kolomeichuk SN, Terrano DT, Lyle CS,
Sabapathy K and Chambers TC: Distinct signaling pathways of
microtubule inhibitors - vinblastine and Taxol induce JNK-dependent
cell death but through AP-1-dependent and AP-1-independent
mechanisms, respectively. FEBS J. 275:1889–1899. 2008. View Article : Google Scholar
|
|
23
|
Lagadinou ED, Ziros PG, Tsopra OA, Dimas
K, Kokkinou D, Thanopoulou E, Karakantza M, Pantazis P,
Spyridonidis A and Zoumbos NC: c-Jun N-terminal kinase activation
failure is a new mechanism of anthracycline resistance in acute
myeloid leukemia. Leukemia. 22:1899–1908. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zerp SF, Stoter R, Kuipers G, Yang D,
Lippman ME, van Blitterswijk WJ, Bartelink H, Rooswinkel R, Lafleur
V and Verheij M: AT-101, a small molecule inhibitor of
anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway
and enhances radiation-induced apoptosis. Radiat Oncol. 4:472009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kan Z, Jaiswal BS, Stinson J, Janakiraman
V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J,
Moorhead M, Chaudhuri S, Tomsho LP, Peters BA, Pujara K, Cordes S,
Davis DP, Carlton VE, Yuan W, Li L, Wang W, Eigenbrot C, Kaminker
JS, Eberhard DA, Waring P, Schuster SC, Modrusan Z, Zhang Z, Stokoe
D, de Sauvage FJ, Faham M and Seshagiri S: Diverse somatic mutation
patterns and pathway alterations in human cancers. Nature.
466:869–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tricker E, Arvand A, Kwan R, Chen GY,
Gallagher E and Cheng G: Apoptosis induced by cytoskeletal
disruption requires distinct domains of MEKK1. PLoS One.
6:e173102011. View Article : Google Scholar : PubMed/NCBI
|
